Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Environmental and cosmetic factors, including heat, chemicals, and sun exposure, can cause hair loss and damage.

Both methods improve hair density and thickness; double-spin may be more effective.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Adjuvants, diet changes, and laser therapy may improve male pattern hair loss.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Combining light therapy and microneedling shows promise for treating female hair loss.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The medication lopinavir-ritonavir may cause severe hair loss.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

Combination therapy works best for female hair loss, increasing density and thickness.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Scientists created a colored thread-like material containing a common hair loss treatment, which slowly releases the treatment over time, potentially offering an effective, neat, and visually appealing solution for hair loss.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

PHAT may improve hair growth better than PRP alone.

Trichoscopy is useful for correctly diagnosing tinea capitis in adults with unexplained hair loss.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Terbinafine can cause hair loss.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Focal atrichia helps diagnose female pattern hair loss.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Older age, family history, and low iron levels increase the risk of female hair loss.